TNF and polymyositis: Anti-TNF-α therapy inhibits the cytotoxic T lymphocyte response that would normally suppress the autoreactive B-cell response, promoting humoral autoimmunity and increasing the type-I interferon system, that has been implicated in the pathogenesis of DM and PM [22, 29, 39, 51].